Back

Relationship between lipoprotein(a) and endogenous fibrinolytic status in patients with STEMI

1 September 2024 (17:00 - 17:50)
Organised by: Logo
Congress Presentation Part of: Advancements in cardiovascular therapies for ST-elevation myocardial infarction: from molecular insights to clinical applications Biomarkers ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Doctor Joshua Harry Leader

East and North Hertfordshire NHS Trust, Stevenage (United Kingdom of Great Britain & Northern Ireland)

9 More presentations in this session

Presentation thumbnail
The clinical characteristics and prognosis of patients with acute non-ST-segment elevation myocardial infarction complicated with impaired activity daily living
Professor K. Chen (Tianjin, CN)
Abstract Slides Video
Presentation thumbnail
ORBI risk score and inflammatory response in patients with acute ST-elevation myocardial infarction
Doctor J. Kunkel (Copenhagen, DK)
Abstract Slides Video
Presentation thumbnail
Combined activation of complement and coagulation is associated with myocardial injury in ST-elevation myocardial infarction
Mr K. Kluge (Oslo, NO)
Abstract Slides Video
Presentation thumbnail
Angiotensin-II receptor type 1 and endothelin-1 receptor type A agonistic autoantibodies in patients with STEMI: new kids on the block
Doctor G. Civieri (Padova, IT)
Abstract Slides Video
Presentation thumbnail
Prognostic impact of composite lipid indices in patients with acute coronary syndrome undergoing percutaneous coronary intervention
Professor A. Hernandez (Storrs, US)
Abstract Slides Video

Access the full session

Session thumbnail
Advancements in cardiovascular therapies for ST-elevation myocardial infarction: from molecular insights to clinical applications

The Event

Event poster

ESC Congress 2024

1 September 2024 17:00 CET
You may be interested in
thumbnail
Congress Presentation
Lipoprotein(a) plama levels during myocardial infarction
thumbnail
Congress Presentation
Lp(a) measurement in younger patients following ST-elevation myocardial infarction: insights from a contemporary regional registry.
thumbnail
Congress Presentation
The role of lipoprotein(a) in myocardial damage and 1-year clinical outcomes after ST-segment elevation myocardial infarction

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources